Who
Christian Heidbreder
Chief Scientific Officer
Company insider
Files Form 4 as: Chief Scientific Officer, Indivior Pharmaceuticals.
In numbers
- Trades disclosed
- 14
- Buys
- 0
- Sells
- 2
- Bought
- $0
- Sold
- $2.9M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 9 Feb 2026
- Last trade
- 10 Jul 2026
- Last filed
- 13 Jul 2026
Companies traded
Activity over time
1 Jun – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Jul 2026filed 13 Jul 2026 | INDV Indivior PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $765K18,586 at $41.14 | filing |
| 10 Jul 2026filed 13 Jul 2026 | INDV Indivior PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $765K18,586 at $41.14 | filing |
| 11 Jun 2026filed 12 Jun 2026 | INDV Indivior PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $707K18,586 at $38.06 | filing |
| 11 Jun 2026filed 12 Jun 2026 | INDV Indivior PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $707K18,586 at $38.06 | filing |
| 3 Mar 2026filed 5 Mar 2026 | INDV Indivior PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | —101,544 | filing |
| 3 Mar 2026filed 5 Mar 2026 | INDV Indivior PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $1.5M45,797 at $31.98 | filing |
| 3 Mar 2026filed 5 Mar 2026 | INDV Indivior Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —132,565 | filing |
| 3 Mar 2026filed 5 Mar 2026 | INDV Indivior Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —132,565 | filing |
| 3 Mar 2026filed 5 Mar 2026 | INDV Indivior PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | —101,544 | filing |
| 3 Mar 2026filed 5 Mar 2026 | INDV Indivior PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $1.5M45,797 at $31.98 | filing |
| 10 Feb 2026filed 12 Feb 2026 | INDV Indivior PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —33,622 at $0.00 | filing |
| 10 Feb 2026filed 12 Feb 2026 | INDV Indivior PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —33,622 at $0.00 | filing |
| 9 Feb 2026filed 12 Feb 2026 | INDV Indivior Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —132,565 at $0.00 | filing |
| 9 Feb 2026filed 12 Feb 2026 | INDV Indivior Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —132,565 at $0.00 | filing |
News
Analyzing Indivior (NASDAQ:INDV) and Palisade Bio (NASDAQ:PALI)INDV · dailypolitical.com · 24 Oct 2026Head-To-Head Survey: Cronos Group (NASDAQ:CRON) versus Indivior (NASDAQ:INDV)INDV · dailypolitical.com · 22 Oct 2026Contrasting Orion OYJ (OTCMKTS:ORINY) & Indivior (NASDAQ:INDV)INDV · themarketsdaily.com · 19 Oct 2026
0 headlines in the last 90 days name Christian Heidbreder; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.